Please assess the completion status of the following clinical trial:

Trial Title: Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Body mass index (BMI) between 30.0-39.0 kg/m2 (obese)~* Females who consent to using double barrier method of contraception, are post-menopausal and older than 50 years, or have had total hysterectomy~Exclusion Criteria:~* Clinically significant diseases~* Blood pressure greater than 140/90 mmHg~* Evidence of depression~* Recent diet attempts, treatment with diet drugs (within 3 months)~* Liposuction or other surgery for weight loss within the last year~* Evidence of eating disorders (bulimia, binge eating)~* Restricted diets (Kosher, vegetarian)~* Smoker or history of drug or alcohol abuse~* Females of childbearing potential: positive pregnancy test

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: EXPERIMENTAL): None
- C (Type: EXPERIMENTAL): None
- D (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).